These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 203056)

  • 21. Adenylate cyclase-cyclic AMP-phosphodiesterase system in microdissected brain areas of normotensive and spontaneously hypertensive rats.
    Bahner U; Palkovits M; Geiger H; Schmid G; Heidland A
    J Chem Neuroanat; 1989; 2(1):45-55. PubMed ID: 2551340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of the synthetic analog of prostaglandin E2 sulprostone on the adenylate cyclase system in decidual tissue of women].
    Goncharova VN; Morozova MS; Razina LG; Astakhova TM; Manuilova IA
    Vopr Med Khim; 1989; 35(6):55-9. PubMed ID: 2560871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effect of pituitary hormones on phosphodiesterase and adenyl cyclase activity of brain tissue in vitro].
    Bulatov AA; Dzhaliashvili TA; Pankov IuA
    Biull Eksp Biol Med; 1981 Apr; 91(4):429-31. PubMed ID: 6266549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Essential athrombia: study of a new case.
    Inceman S; Tangün Y
    Thromb Diath Haemorrh; 1975 Apr; 33(2):278-85. PubMed ID: 1138423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular action of antidiuretic hormone in mice with inherited vasopressin-resistant urinary concentrating defects.
    Dousa TP; Valtin H
    J Clin Invest; 1974 Sep; 54(3):753-62. PubMed ID: 4368480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of 1-(3-chloroanilino)-4-phenylphthalazine (MY-5445), a specific inhibitor of cyclic GMP phosphodiesterase, on human platelet aggregation.
    Hagiwara M; Endo T; Kanayama T; Hidaka H
    J Pharmacol Exp Ther; 1984 Feb; 228(2):467-71. PubMed ID: 6141286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S; Shibata S; Kobayashi B
    Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The regulation of skeletal muscle alanine and glutamine formation and release in experimental chronic uremia in the rat: subsensitivity of adenylate cyclase and amino acid release to epinephrine and serotonin.
    Garber AJ
    J Clin Invest; 1978 Sep; 62(3):633-41. PubMed ID: 211145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of systematic muscular work on the tissue activity of adenylate cyclase and 3',5'-AMP-phosphodiesterase].
    Iakovlev NN
    Ukr Biokhim Zh; 1974; 46(1):18-24. PubMed ID: 4363030
    [No Abstract]   [Full Text] [Related]  

  • 31. [Cyclic adenosine monophosphate and atherogenic factors].
    Gerasimova EN
    Vopr Med Khim; 1977; (6):789-96. PubMed ID: 202091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proceedings: Adenylate cyclase and phosphodiesterase in rat gastric mucosa.
    Ruoff HJ; Sewing KF
    Acta Hepatogastroenterol (Stuttg); 1975 Feb; 22(1):63-4. PubMed ID: 164097
    [No Abstract]   [Full Text] [Related]  

  • 33. Evidence for regulatory control of canine platelet phosphodiesterase.
    Boudreaux MK; Dodds WJ; Slauson DO; Catalfamo JL
    Biochem Biophys Res Commun; 1986 Oct; 140(2):589-94. PubMed ID: 3022725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lithium modulation of second messenger signal amplification in man: inhibition of phosphatidylinositol-specific phospholipase C and adenylate cyclase activity.
    Ebstein RP; Lerer B; Bennett ER; Shapira B; Kindler S; Shemesh Z; Gerstenhaber N
    Psychiatry Res; 1988 Apr; 24(1):45-52. PubMed ID: 2839860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenylate cyclase and phosphodiesterase activity in the platelet release abnormality.
    Chesney CM; Baker AS; Carvalho AC; Ozer A; Meissner GF; Colman RW
    Thromb Haemost; 1977 Dec; 38(4):971-83. PubMed ID: 203056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclic 3',5'-adenosine monophosphate in human blood platelets. II. Effect of N6-2'-o-dibutyryl cyclic 3',5'-adenosine monophosphate on platelet function.
    Salzman EW; Levine L
    J Clin Invest; 1971 Jan; 50(1):131-41. PubMed ID: 4322665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
    Walter F; Vulliemoz Y; Verosky Y; Triner L
    Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Desensitization of epinephrine-initiated platelet aggregation does not alter binding to the alpha 2-adrenergic receptor or receptor coupling to adenylate cyclase.
    Motulsky HJ; Shattil SJ; Ferry N; Rozansky D; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):1-6. PubMed ID: 2418346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action of 2-(diethylamino)-7-ethoxychromone on human platelets.
    Leoncini G; Maresca M; Colao C; Buzzi E; Mazzei M
    Cell Biochem Funct; 1991 Apr; 9(2):79-85. PubMed ID: 1718622
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclic nucleotides and platelet aggregation. Effect of aggregating agents on the activity of cyclic nucleotide-metabolizing enzymes.
    Barber AJ
    Biochim Biophys Acta; 1976 Sep; 444(2):579-95. PubMed ID: 9149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.